7lcs
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Improved Feline Drugs as SARS-CoV-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization for Enhanced Bioavailability== | |
| - | + | <StructureSection load='7lcs' size='340' side='right'caption='[[7lcs]]' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7LCS OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7LCS FirstGlance]. <br> | |
| - | + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7lcs FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7lcs OCA], [https://pdbe.org/7lcs PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7lcs RCSB], [https://www.ebi.ac.uk/pdbsum/7lcs PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7lcs ProSAT]</span></td></tr> | |
| - | [[Category: | + | </table> |
| - | [[Category: | + | __TOC__ |
| - | [[Category: Khan | + | </StructureSection> |
| - | [[Category: Lemieux | + | [[Category: Large Structures]] |
| - | [[Category: | + | [[Category: Arutyunova E]] |
| + | [[Category: Khan MB]] | ||
| + | [[Category: Lemieux MJ]] | ||
| + | [[Category: Young HS]] | ||
Revision as of 09:57, 7 July 2021
Improved Feline Drugs as SARS-CoV-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization for Enhanced Bioavailability
| |||||||||||
